Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

S. Gourgou-Bourgade; D. Cameron; P. Poortmans; B. Asselain; D. Azria; F. Cardoso; R. A'Hern; J. Bliss; J. Bogaerts; H. Bonnefoi; E. Brain; M. J. Cardoso; B. Chibaudel; R. Coleman; T. Cufer; L. Dal Lago; F. Dalenc; E. de Azambuja; M. Debled; S. Delaloge; T. Filleron; J. Gligorov; M. Gutowski; W. Jacot; C. Kirkove; G. MacGrogan; S. Michiels; I. Negreiros; B. V. Offersen; F. Penault Llorca; G. Pruneri; H. Roche; N. S. Russell; F. Schmitt; V. Servent; B. Thürlimann; M. Untch; J. A. van der Hage; G. van Tienhoven; H. Wildiers; J. Yarnold; F. Bonnetain; S. Mathoulin-Pélissier; C. Bellera; T. S. Dabakuyo-Yonli

doi:https://doi.org/10.1093/annonc/mdv478

Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

S. Gourgou-Bourgade, D. Cameron, P. Poortmans, B. Asselain, D. Azria, F. Cardoso, R. A'Hern, J. Bliss, J. Bogaerts, H. Bonnefoi, E. Brain, M. J. Cardoso, B. Chibaudel, R. Coleman, T. Cufer, L. Dal Lago, F. Dalenc, E. de Azambuja, M. Debled, S. DelalogeT. Filleron, J. Gligorov, M. Gutowski, W. Jacot, C. Kirkove, G. MacGrogan, S. Michiels, I. Negreiros, B. V. Offersen, F. Penault Llorca, G. Pruneri, H. Roche, N. S. Russell, F. Schmitt, V. Servent, B. Thürlimann, M. Untch, J. A. van der Hage, G. van Tienhoven, H. Wildiers, J. Yarnold, F. Bonnetain, S. Mathoulin-Pélissier, C. Bellera, T. S. Dabakuyo-Yonli

Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review

27 Citations (Scopus)

Original language	English
Pages (from-to)	2505
Journal	Annals of Oncology
Volume	26
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdv478
Publication status	Published - 2015
Externally published	Yes

Access to Document

https://doi.org/10.1093/annonc/mdv478

Cite this

Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M. J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., de Azambuja, E., Debled, M., ... Dabakuyo-Yonli, T. S. (2015). Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. Annals of Oncology, 26(12), 2505. https://doi.org/10.1093/annonc/mdv478

Gourgou-Bourgade, S. ; Cameron, D. ; Poortmans, P. et al. / Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. In: Annals of Oncology. 2015 ; Vol. 26, No. 12. pp. 2505.

@article{a989d552306041b796ae8eae50346197,

title = "Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106",

author = "S. Gourgou-Bourgade and D. Cameron and P. Poortmans and B. Asselain and D. Azria and F. Cardoso and R. A'Hern and J. Bliss and J. Bogaerts and H. Bonnefoi and E. Brain and Cardoso, {M. J.} and B. Chibaudel and R. Coleman and T. Cufer and {Dal Lago}, L. and F. Dalenc and {de Azambuja}, E. and M. Debled and S. Delaloge and T. Filleron and J. Gligorov and M. Gutowski and W. Jacot and C. Kirkove and G. MacGrogan and S. Michiels and I. Negreiros and Offersen, {B. V.} and {Penault Llorca}, F. and G. Pruneri and H. Roche and Russell, {N. S.} and F. Schmitt and V. Servent and B. Th{\"u}rlimann and M. Untch and {van der Hage}, {J. A.} and {van Tienhoven}, G. and H. Wildiers and J. Yarnold and F. Bonnetain and S. Mathoulin-P{\'e}lissier and C. Bellera and Dabakuyo-Yonli, {T. S.}",

year = "2015",

doi = "https://doi.org/10.1093/annonc/mdv478",

language = "English",

volume = "26",

pages = "2505",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

Gourgou-Bourgade, S, Cameron, D, Poortmans, P, Asselain, B, Azria, D, Cardoso, F, A'Hern, R, Bliss, J, Bogaerts, J, Bonnefoi, H, Brain, E, Cardoso, MJ, Chibaudel, B, Coleman, R, Cufer, T, Dal Lago, L, Dalenc, F, de Azambuja, E, Debled, M, Delaloge, S, Filleron, T, Gligorov, J, Gutowski, M, Jacot, W, Kirkove, C, MacGrogan, G, Michiels, S, Negreiros, I, Offersen, BV, Penault Llorca, F, Pruneri, G, Roche, H, Russell, NS, Schmitt, F, Servent, V, Thürlimann, B, Untch, M, van der Hage, JA, van Tienhoven, G, Wildiers, H, Yarnold, J, Bonnetain, F, Mathoulin-Pélissier, S, Bellera, C & Dabakuyo-Yonli, TS 2015, 'Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106', Annals of Oncology, vol. 26, no. 12, pp. 2505. https://doi.org/10.1093/annonc/mdv478

Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. / Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P. et al.
In: Annals of Oncology, Vol. 26, No. 12, 2015, p. 2505.

Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review

TY - JOUR

T1 - Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

AU - Gourgou-Bourgade, S.

AU - Cameron, D.

AU - Poortmans, P.

AU - Asselain, B.

AU - Azria, D.

AU - Cardoso, F.

AU - A'Hern, R.

AU - Bliss, J.

AU - Bogaerts, J.

AU - Bonnefoi, H.

AU - Brain, E.

AU - Cardoso, M. J.

AU - Chibaudel, B.

AU - Coleman, R.

AU - Cufer, T.

AU - Dal Lago, L.

AU - Dalenc, F.

AU - de Azambuja, E.

AU - Debled, M.

AU - Delaloge, S.

AU - Filleron, T.

AU - Gligorov, J.

AU - Gutowski, M.

AU - Jacot, W.

AU - Kirkove, C.

AU - MacGrogan, G.

AU - Michiels, S.

AU - Negreiros, I.

AU - Offersen, B. V.

AU - Penault Llorca, F.

AU - Pruneri, G.

AU - Roche, H.

AU - Russell, N. S.

AU - Schmitt, F.

AU - Servent, V.

AU - Thürlimann, B.

AU - Untch, M.

AU - van der Hage, J. A.

AU - van Tienhoven, G.

AU - Wildiers, H.

AU - Yarnold, J.

AU - Bonnetain, F.

AU - Mathoulin-Pélissier, S.

AU - Bellera, C.

AU - Dabakuyo-Yonli, T. S.

PY - 2015

Y1 - 2015

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949997577&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/26467471

U2 - https://doi.org/10.1093/annonc/mdv478

DO - https://doi.org/10.1093/annonc/mdv478

M3 - Erratum/Corrigendum

C2 - 26467471

SN - 0923-7534

VL - 26

SP - 2505

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F et al. Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. Annals of Oncology. 2015;26(12):2505. doi: https://doi.org/10.1093/annonc/mdv478

Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

Access to Document

Other files and links

Cite this